Resources

Type of publications
Regions
Diseases

5255 results found

2021 ∙ Jacobs, J. W. Booth, G. S.

COVID-19 and Immune-Mediated RBC Destruction

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Falsaperla, R. Leone, G. Familiari, M. Ruggieri, M.

COVID-19 vaccination in pregnant and lactating women: a systematic review

  • Pregnant women
  • COVID-19
  • Safety
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Al-Amer, R. Maneze, D. Everett, B. Montayre, J. Villarosa, A. R. Dwekat, E. Salamonson, Y.

COVID-19 vaccination intention in the first year of the pandemic: A systematic review

  • All age groups
  • Healthcare workers
  • Parents/caregivers
  • COVID-19
  • Coverage
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2021 ∙ Yasmin, F. Najeeb, H. Moeed, A. Naeem, U. Asghar, M. S. Chughtai, N. U. Yousaf, Z. Seboka, B. T. Ullah, I. Lin, C. Y. Pakpour, A. H.

COVID-19 Vaccine Hesitancy in the United States: A Systematic Review

  • Americas
  • United States of America
  • All age groups
  • Healthcare workers
  • Pregnant women
  • Parents/caregivers
  • COVID-19
  • Acceptance
  • Coverage
  • Ethical issues
Methodological quality (AMSTAR 2):
Not applicable
2021 ∙ Sallam, M.

Covid-19 vaccine hesitancy worldwide: A concise systematic review of vaccine acceptance rates

  • All age groups
  • Healthcare workers
  • Parents/caregivers
  • COVID-19
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2021 ∙ Gong, Inna Vijenthira, Abi Betschel, Stephen Hicks, Lisa K. Cheung, Matthew

COVID-19 Vaccine Response in Patients with Hematologic Malignancy: A Systematic Review and Meta-Analysis

  • All age groups
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Bilotta, C. Perrone, G. Adelfio, V. Spatola, G. F. Uzzo, M. L. Argo, A. Zerbo, S.

COVID-19 Vaccine-Related Thrombosis: A Systematic Review and Exploratory Analysis

  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Gonzalez Rodriguez, P. Perez-Moneo Agapito, B. Albi Rodriguez, M. S. Aizpurua Galdeano, P. Aparicio Rodrigo, M. Fernandez Rodriguez, M. M. Esparza Olcina, M. J. Ochoa Sangrador, C. en representacion del Grupo de Trabajo de Pediatria Basada en la Evidencia de la, A. E. P. y AEPap

COVID-19: Critical appraisal of the evidence

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Cavanna, L. Citterio, C. Toscani, I.

Covid‐19 vaccines in cancer patients. Seropositivity and safety. systematic review and meta‐analysis

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Ishiwada, N.

Current situation and need for prevention of invasive pneumococcal disease and pneumococcal pneumonia in 6- to 64-year-olds in Japan

  • Western Pacific
  • Japan
  • All age groups
  • Pneumococcal disease
  • Coverage
  • Economic aspects
Methodological quality (AMSTAR 2):
Not applicable
Loading...